Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 6 Apr 2011 |
| Constitution of the Board of Directors in Genmab A/S and Grant of Warrants to a Board Member and Employees | 6 Apr 2011 |
| Report Pursuant to Section 28a of the Danish Securities Trading Act | 6 Apr 2011 |
| Genmab's Annual Report 2010 | 15 Mar 2011 |
| Genmab A/S Summons Annual General Meeting | 15 Mar 2011 |